| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/TERM.414 |
| P8608 | Fatcat ID | release_zstwizrcube5njy5khpocvjuqu |
| P932 | PMC publication ID | 3412051 |
| P698 | PubMed publication ID | 21774080 |
| P50 | author | Gordana Vunjak-Novakovic | Q54394 |
| Matthias Lütolf | Q87051644 | ||
| Jeroen Rouwkema | Q38327889 | ||
| Jos Malda | Q38327909 | ||
| P2093 | author name string | Ivan Martin | |
| Susan Gibbs | |||
| P2860 | cites work | Growth factors, matrices, and forces combine and control stem cells | Q29616603 |
| Engineered microenvironments for controlled stem cell differentiation | Q30488054 | ||
| Engineering anatomically shaped human bone grafts | Q33734739 | ||
| Nuclear reprogramming to a pluripotent state by three approaches | Q33980410 | ||
| Vascularized organoid engineered by modular assembly enables blood perfusion | Q34984356 | ||
| The role of bioreactors in tissue engineering | Q35646105 | ||
| Bioreactors for tissue mass culture: design, characterization, and recent advances | Q36196911 | ||
| Engineering tissues for in vitro applications | Q36595374 | ||
| Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs | Q36775306 | ||
| Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling | Q36828764 | ||
| Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery. | Q36953868 | ||
| In vitro irritation models and immune reactions | Q37384209 | ||
| Cardiac tissue engineering using perfusion bioreactor systems | Q37391209 | ||
| Enhancing oxygen solubility using hemoglobin- and perfluorocarbon-based carriers | Q37410023 | ||
| In vitro microscale systems for systematic drug toxicity study | Q37585148 | ||
| Intrinsic extracellular matrix properties regulate stem cell differentiation. | Q37607685 | ||
| Lab-on-a-chip devices as an emerging platform for stem cell biology. | Q37765821 | ||
| Supply of nutrients to cells in engineered tissues | Q37854428 | ||
| The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. | Q40509905 | ||
| Artificial Stem Cell Niches | Q41861617 | ||
| Oxygen generating scaffolds for enhancing engineered tissue survival | Q42806128 | ||
| Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. | Q51134090 | ||
| Tissue assembly and organization: developmental mechanisms in microfabricated tissues. | Q51930739 | ||
| Trends in biomaterials research: An analysis of the scientific programme of the World Biomaterials Congress 2008 | Q63989060 | ||
| SnapShot: Bioreactors systems in tissue engineering (TE) & regenerative medicine (RM) | Q83158337 | ||
| Bioreactors in tissue engineering: scientific challenges and clinical perspectives | Q83483962 | ||
| Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products | Q84341274 | ||
| P433 | issue | 8 | |
| P921 | main subject | tissue engineering | Q1540285 |
| P304 | page(s) | e164-7 | |
| P577 | publication date | 2011-02-24 | |
| P1433 | published in | Journal of Tissue Engineering and Regenerative Medicine | Q15746559 |
| P1476 | title | In vitro platforms for tissue engineering: implications for basic research and clinical translation | |
| P478 | volume | 5 |
| Q26825657 | 3D Bioprinting of Cartilage for Orthopedic Surgeons: Reading between the Lines |
| Q42586736 | Autologous tissue patch rich in stem cells created in the subcutaneous tissue |
| Q33733279 | Biomechanics and mechanobiology in functional tissue engineering |
| Q36792159 | Directed differentiation of size-controlled embryoid bodies towards endothelial and cardiac lineages in RGD-modified poly(ethylene glycol) hydrogels |
| Q36145028 | Distributed and Lumped Parameter Models for the Characterization of High Throughput Bioreactors |
| Q36840191 | Elastomeric free-form blood vessels for interconnecting organs on chip systems |
| Q35667383 | Evaluation of polycaprolactone scaffold with basic fibroblast growth factor and fibroblasts in an athymic rat model for anterior cruciate ligament reconstruction. |
| Q39597401 | Extracellular matrix deposition and scaffold biodegradation in an in vitro three-dimensional model of bone by X-ray computed microtomography. |
| Q37947420 | In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies |
| Q43486160 | In vitro and in vivo evaluation of heparin mediated growth factor release from tissue-engineered constructs for anterior cruciate ligament reconstruction. |
| Q38134206 | Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors |
| Q28650026 | On the genealogy of tissue engineering and regenerative medicine |
| Q38258077 | Skeletal muscle tissue engineering: strategies for volumetric constructs |
| Q88250579 | Surgical perspectives regarding application of biomaterials for the management of large congenital diaphragmatic hernia defects |
| Q38644027 | Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models |
| Q37745063 | Vascularization Potential of Electrospun Poly(L-Lactide-co-Caprolactone) Scaffold: The Impact for Tissue Engineering. |
Search more.